This website is intended for healthcare professionals only

touchNEUROLOGY

Search

Trending Topic

Developed by Touch

European Stroke Organisation Conference 2026: Expanding the boundaries of acute stroke care

Federica Rizzo, Ettore Nicolini, Antonio Ciacciarelli

The 12th European Stroke Organisation Conference (Maastricht, May 6–8, 2026) was dominated by studies testing the limits of acute stroke therapy, from thrombectomy and neuroprotection to secondary prevention. Supplementary Table 1 provides a comprehensive overview of the major studies presented during the conference. The large-core indication for thrombectomy is recent, and the ATLAS (Endovascular thrombectomy […]

touchREVIEWS in Neurology. 2026;22(1):Online ahead of journal publication

Neurological Oncology

Malignant brain tumours and the role of genetically engineered mice models

Published Online: Mar 24th 2015

The ways in which mice can be used to investigate the causes of malignant brain tumours.

Trending Topic

Developed by Touch

Riccardo Soffietti, EAN 2018 – Advances in personalised therapies for brain tumours (Part 2)

Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in brain tumours. Part 2 of 2. Questions 1. What are the most promising agents targeting […]

Related Videos in Neurological Oncology

Riccardo Soffietti, EAN 2018 – Advances in personalised therapies for brain tumours (Part 1)

Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in ...

EAN 2017 – Riccardo Soffietti Interview – Part 3

EAN Programme Committee Member, Prof. Riccardo Soffietti, provides his insights on neuro-oncology coverage at this year’s EAN congress. Part 3 of 3. View Part 1 here. View Part 2 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at ...

EAN 2017 – Riccardo Soffietti Interview – Part 2

EAN Programme Committee Member, Prof. Riccardo Soffietti, talks about unmet needs and what he considers will be the most exciting/promising developments in neuro-oncology over the next 2 years. Part 2 of 3. View Part 1 here. View Part 3 here. Speaker disclosures: nothing to ...

EAN 2017 – Riccardo Soffietti Interview – Part 1

EAN Programme Committee Member, Prof. Riccardo Soffietti, discusses the most significant recent developments in neuro-oncology. Part 1 of 3. View Part 2 here. View Part 3 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at the 3rd Congress of ...

IDoR 2014_Thurnher.png

IDoR 2014 - ECR On Demand: Basic 2 'Basic Session on Neuroradiology' (Brain tumours, M.M. Thurnher)

M.M. Thurnher discusses brain tumour radiology at ECR 2014.

Radiosurgery Versus Radiotherapy Followed by Whole Brain Radiation for Brain Metastases

Kurt Jaeckle, MD, professor of neurology and oncology, Mayo Clinic, discusses radiosurgery versus radiotherapy followed by whole brain radiation for brain metastases.

adjuvant whole brain radiation therapy

Dr Buckner (Mayo Clinic, Rochester, USA) presents, at a press conference at ASCO 2015, a federally funded phase III trial that is providing additional information regarding a long-standing discussion about the impact of adjuvant whole brain radiation therapy (WBRT) on cognitive ...

Fluorescent Guided Glioblastoma Resection

Demonstration of the benefits and limitations of fluorescent guided surgery for resection of glioblastoma.

Advanced Treatment for Brain and Spine Tumors

The UF Health Cancer Center at Orlando is one of very few centers in the southeast to offer dedicated neuro oncology, neuro radiation oncology, and tumor neurosurgery teams that specialize in treating brain and spine tumors.

A Retrospective Focus on Glioblastoma Treatment and Bevacizumab

From ASCO 2014, Dr. Annick Desjardins of Duke University discusses the retrospective focus on glioblastoma treatment and the use of bevacizumab.

Diagnosing and Treating Pituitary Adenomas: A Multidisciplinary Approach

Susan Challinor, MD, an endocrinologist at UPMC, discusses the diagnosis and treatment of pituitary adenomas and details why a multidisciplinary approach should be considered.

Peptide Cancer Vaccine for Glioblastoma

Peptide Cancer Vaccine for Glioblastoma

Glioblastoma (GBT) is the most prevalent and most aggressive form of cancers of the brain and nervous systems. GBT is a dismal disease with one year survival rates at 30% and five year survival rates at 3%.

Latest articles videos and clinical updates - straight to your inbox

Sign Up

Login

Sign Up FREE

Log into your Touch Account

Keep track of your clinical interests and newsletter subscriptions.

Error:

Forgot Password?

Or log in with

By proceeding, you agree to our terms & conditions.

For information about how we
use your data, see our privacy policy.

Register now for FREE Access

Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.

Sign up with an Email

Sign up with Google

Sign up with Facebook

Sign up with LinkedIn

Sign up with Microsoft

Already have an Account?

Login

Sign up with an Email

Or use a Social Account.

Error:

By clicking sign up you agree to the website
terms & conditions and privacy policy.

Register now for FREE access

Already registered? Login below.

Register

Login